TY  - JOUR 
AU  - Trento, Cristina
AU  - Bernardo, Maria Ester
AU  - Nagler, Arnon
AU  - Kuçi, Selim
AU  - Bornhäuser, Martin
AU  - Köhl, Ulrike
AU  - Strunk, Dirk
AU  - Galleu, Antonio
AU  - Sánchez Guijo Martín, Fermín
AU  - Gaipa, Giuseppe
AU  - Introna, Martino
AU  - Bukauskas, Adomas
AU  - Le Blanc, Katarina
AU  - Apperley, Jane
AU  - Roelofs, Helene
AU  - Van Campenhout, Ann
AU  - Beguin, Yves
AU  - Kuball, Jürgen
AU  - Lazzari, Lorenza
AU  - Avanzini, Maria Antonietta
AU  - Fibbe, Willem
AU  - Chabannon, Christian
AU  - Bonini, Chiara
AU  - Dazzi, Francesco
PY  - 2018
SN  - 1083-8791
UR  - http://hdl.handle.net/10366/146604
AB  - [EN]The immunosuppressive properties of mesenchymal stromal cells (MSC) have been successfully tested to control clinical severe graft-versus host disease and improve survival. However, clinical studies have not yet provided conclusive evidence of...
LA  - eng
PB  - Elsevier
KW  - Mesenchymal stromal cells
KW  - Graft-versus-host disease
KW  - Cellular therapy
KW  - Manufacturing
KW  - Product specification
KW  - Release criteria
KW  - Mesenchymal Stromal Cells
KW  - Graft vs Host Disease
KW  - Hematology
TI  - Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
DO  - 10.1016/j.bbmt.2018.07.015
T2  - Biology of Blood and Marrow Transplantation
VL  - 24
M2  - 2365
ER  -